Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Feb 04, 2021 9:40am
97 Views
Post# 32469104

RE:RE:RE:PreMarket Mkt Making guesses

RE:RE:RE:PreMarket Mkt Making guessesThere's some chunky sellers in there putting multiple 20,000 share offers out there to get hit. It always amazes me how many people are willing to ditch this stock even when there's decent news to support a 12 month trial.  Who are these sellers and where do they come from?  They have to not know a whole lot about the company.

Wino115 wrote: They  tried to drive it down the last 5 minutes but solid orders kept coming in above $3 and kept it there.  Nice open, more buying interest and depth than selling interest so just might hold and go up from here. 


Wino115 wrote: Solid buying interest at $3.20 level.  Going back up. Market makers will be worried on covering their shorts!  I think if it hits $3.50, it will really break through as those 2 mil shorted shares I've guessed at can't have seen more than 1mil covered.  $3.50 break will lead to $4.00.  That's my totally uneducated  technical guess. 


Wino115 wrote: So about 2 mil shares seem to have traded above that $3.70-ish level.  If we assume most of those were shorted by market makers, they need to buy 2mil shares below there.  I'm guessing they want to do that before the market opens or close to getting done before.  So perhaps they are buying here and they have that lid on at $3.50.   

I guess it's algo's and Europeans buying in pre-market mostly.  If premarket hangs in here at $3-$3.20, I can see there at least being some kind of blip for Canadian and US demand in the morning and maybe we'll see those new "LT shareholders" Dubuc mentioned step in to soak up the weak hands.  May be a chance we hold that $3.20 for the close.  

 




<< Previous
Bullboard Posts
Next >>